Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - 55 |
| Updated: | 6/28/2018 |
| Start Date: | June 2016 |
| End Date: | June 2020 |
| Contact: | Christina Luddy, BS |
| Email: | christina.luddy@yale.edu |
| Phone: | 203-932-5711 |
The purpose of the study is to characterize the acute effects of cannabinoids in women
relative to men and to begin probing the mechanisms that may underlie gender differences.
relative to men and to begin probing the mechanisms that may underlie gender differences.
To characterize the acute effects of oral Dronabinol (10 mg capsule) in women relative to men
and to begin probing the mechanisms that may underlie gender differences.
and to begin probing the mechanisms that may underlie gender differences.
Inclusion Criteria:
- At least one lifetime exposure to cannabis
- Good physical and mental health
Exclusion Criteria:
- Cannabis naive individuals
- Major current or recent stressors
- Taking estrogen supplements or oral contraceptive pills (for women)
- Sesame oil allergy
We found this trial at
1
site
West Haven, Connecticut 06516
Principal Investigator: Mohini Ranganathan, MD
Phone: 203-932-5711
Click here to add this to my saved trials
